Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University, Stanford, CA 94305-5427 USA.
Nanomedicine (Lond). 2011 Jun;6(4):715-28. doi: 10.2217/nnm.11.19.
Nanoparticles are an essential component in the emerging field of nanomedical imaging and therapy. When deployed in vivo, these materials are typically protected from the immune system by polyethylene glycol (PEG). A wide variety of strategies to coat and characterize nanoparticles with PEG has established important trends on PEG size, shape, density, loading level, molecular weight, charge and purification. Strategies to incorporate targeting ligands are also prevalent. This article presents a background to investigators new to stealth nanoparticles, and suggests some key considerations needed prior to designing a nanoparticle PEGylation protocol and characterizing the performance features of the product.
纳米粒子是新兴的纳米医学成像和治疗领域的重要组成部分。当这些材料在体内应用时,通常会被聚乙二醇(PEG)保护起来,以避免被免疫系统识别。目前已经建立了许多用 PEG 对纳米粒子进行涂层和特性描述的策略,这些策略涉及 PEG 的大小、形状、密度、负载水平、分子量、电荷和纯度等方面。将靶向配体整合到纳米粒子中的策略也很常见。本文为刚接触隐形纳米粒子的研究人员提供了一个背景介绍,并就设计纳米粒子聚乙二醇化方案和描述产品性能特点之前需要考虑的一些关键问题提出了建议。